» Articles » PMID: 7683034

Expression of Thy-1 on Human Hematopoietic Progenitor Cells

Overview
Journal J Exp Med
Date 1993 May 1
PMID 7683034
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Expression of Thy-1 on hematopoietic cells from human fetal liver (FL), cord blood (CB), and bone marrow (BM) was studied with a novel anti-Thy-1 antibody, 5E10. Specificity of 5E10 for human Thy-1 was demonstrated by immunoprecipitation of a 25-35-kD molecule, and the sequence of a cDNA that was cloned by immunoselection of COS cells transfected with a cDNA library derived from a 5E10+ cell line. Two- and three-color immunofluorescence staining experiments revealed that the Thy-1 expression is restricted to, an average, 1-4% of FL, CB, and BM cells, and binding to these cell types is essentially restricted to a very small subset of lymphoid cells and approximately 25% of CD34+ cells. Thy-1+ CD34+ cells were further characterized as CD38lo/CD45RO+/CD45RA-/CD71lo/c-kit(lo) and rhodamine 123dull. When CD34+ cells were sorted on the basis of Thy-1 expression, the majority of clonogenic cells were recovered in the CD34+Thy-1- fraction, whereas the majority of cells capable of producing myeloid colonies after 5-8 wk of long-term culture (long-term culture initiating cells) were recovered in the Thy-1+CD34+ fraction. In addition to CD34+ cells, Thy-1 was found to be expressed on a variable, very small number (< 1%) of CD34- mononuclear cells in BM, CB, and peripheral blood that were further characterized as CD3+ CD4+ lymphocytes. The restricted expression of Thy-1 on primitive hematopoietic cells is in agreement with a previous report (Baum et al., 1992. Proc. Natl. Acad. Sci. USA. 89:2804) in which Thy-1 expression was used to enrich for primitive hematopoietic cells from fetal tissue. Compared with those previous studies, we found Thy-1 expression on a larger proportion of CD34+ cells (25% in our study vs. 5% in Baum et al.) and furthermore performed studies on Thy-1 expression on CD34+ cells from CB, FL, and BM in relation to markers that are known to be differentially expressed on hematopoietic cells. Taken together our results indicate that Thy-1-specific antibody 5E10 is an attractive tool for further studies on the biology and purification of human stem cells.

Citing Articles

Mesenchymal stromal/stem cells from perinatal sources: biological facts, molecular biomarkers, and therapeutic promises.

Allouh M, Rizvi S, Alamri A, Jimoh Y, Aouda S, Ouda Z Stem Cell Res Ther. 2025; 16(1):127.

PMID: 40055783 PMC: 11889844. DOI: 10.1186/s13287-025-04254-0.


High Expression of THY1 in Intestinal Gastric Cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial-Mesenchymal Transition Profile.

Rohan P, Dos Santos E, Abdelhay E, Binato R Genes (Basel). 2024; 15(1).

PMID: 38254918 PMC: 10815053. DOI: 10.3390/genes15010028.


CD90-targeted lentiviral vectors for HSC gene therapy.

Berckmueller K, Thomas J, Taha E, Choo S, Madhu R, Kanestrom G Mol Ther. 2023; 31(10):2901-2913.

PMID: 37550965 PMC: 10556220. DOI: 10.1016/j.ymthe.2023.08.003.


Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage.

Schippel N, Sharma S Exp Hematol. 2023; 123:1-17.

PMID: 37172755 PMC: 10330572. DOI: 10.1016/j.exphem.2023.05.001.


What is new in cancer-associated fibroblast biomarkers?.

Zhao Z, Li T, Yuan Y, Zhu Y Cell Commun Signal. 2023; 21(1):96.

PMID: 37143134 PMC: 10158035. DOI: 10.1186/s12964-023-01125-0.


References
1.
Kemshead J, Heath L, Gibson F, Katz F, Richmond F, Treleaven J . Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations. Br J Cancer. 1986; 54(5):771-8. PMC: 2001544. DOI: 10.1038/bjc.1986.239. View

2.
Spangrude G, Brooks D . Phenotypic analysis of mouse hematopoietic stem cells shows a Thy-1-negative subset. Blood. 1992; 80(8):1957-64. View

3.
Rutledge R, Seligy V, Cote M, Dimock K, Lewin L, Tenniswood M . Rapid synthesis and cloning of complementary DNA from any RNA molecule into plasmid and phage M13 vectors. Gene. 1988; 68(1):151-8. DOI: 10.1016/0378-1119(88)90607-5. View

4.
Buhring H, Asenbauer B, Katrilaka K, Hummel G, Busch F . Sequential expression of CD34 and CD33 antigens on myeloid colony-forming cells. Eur J Haematol. 1989; 42(2):143-9. DOI: 10.1111/j.1600-0609.1989.tb01203.x. View

5.
Andrews R, Singer J, Bernstein I . Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med. 1989; 169(5):1721-31. PMC: 2189320. DOI: 10.1084/jem.169.5.1721. View